Insulin as an autoantigen in NOD/human diabetes

Current Opinion in Immunology
Li ZhangGeorge S Eisenbarth

Abstract

Although multiple islet autoantigens are recognized by T lymphocytes and autoantibodies before the development of type 1A (immune-mediated diabetes), there is increasing evidence that autoimmunity to insulin may be central to disease pathogenesis. Evidence is strongest for the NOD mouse model where blocking immune responses to insulin prevents diabetes, and insulin peptides can be utilized to induce diabetes. In man insulin gene polymorphisms are associated with disease risk, and autoantibodies and T cells reacting with multiple insulin/proinsulin epitopes are present. It is not currently clear why insulin autoimmunity is so prominent and frequent, and though insulin can be used to immunologically prevent diabetes of NOD mice, insulin-based preventive immunoregulation of diabetes in man is not yet possible.

References

Oct 1, 1988·Diabetes·K HaskinsK Lafferty
Jan 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·D Daniel, D R Wegmann
Mar 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·E SimoneG S Eisenbarth
Dec 31, 1997·The Journal of Experimental Medicine·J VerdaguerP Santamaria
May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·M CongiaG Sønderstrup
Mar 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·L YuG S Eisenbarth
Dec 2, 2000·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·S S EapenJ E Gern
Apr 3, 2002·Nature Medicine·Siri Atma W GreeleyHooman Noorchashm
Apr 12, 2002·Proceedings of the National Academy of Sciences of the United States of America·Hiroaki MoriyamaGeorge S Eisenbarth
Mar 18, 2003·The Journal of Clinical Investigation·Karine Thébault-BaumontChristian Boitard
May 3, 2003·The Journal of Clinical Investigation·Raymond J SteptoeLeonard C Harrison
Jun 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Scott M LiebermanTeresa P DiLorenzo
Aug 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Hiroaki MoriyamaGeorge S Eisenbarth
Sep 11, 2003·Diabetes Research and Clinical Practice·Hisayo YokoyamaYoshiki Nishizawa
Feb 3, 2004·The Journal of Clinical Investigation·Sefina ArifMark Peakman
Aug 18, 2004·The Journal of Clinical Investigation·Peter AchenbachEzio Bonifacio
Sep 7, 2004·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·T RustemeyerR J Scheper
Jul 21, 2005·Proceedings of the National Academy of Sciences of the United States of America·Andréa TomaChristian Boitard
Nov 2, 2005·The Journal of Experimental Medicine·Stuart I ManneringAnthony W Purcell

❮ Previous
Next ❯

Citations

Jul 28, 2013·Current Diabetes Reports·Leonard C HarrisonGrant Morahan
Sep 8, 2012·Immunologic Research·Tomasz Sosinowski, George S Eisenbarth
Apr 21, 2010·Immunology and Cell Biology·Laura Santambrogio, Teresa P DiLorenzo
Jun 11, 2010·Proceedings of the National Academy of Sciences of the United States of America·Brian D StadinskiJohn W Kappler
Sep 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Frances CrawfordJohn W Kappler
Feb 18, 2009·The Journal of Experimental Medicine·Cédric LouvetJeffrey A Bluestone
Feb 23, 2012·Cold Spring Harbor Perspectives in Medicine·Xavier Clemente-CasaresPere Santamaria
Mar 7, 2012·Cold Spring Harbor Perspectives in Medicine·Lukas T JekerJeffrey A Bluestone
Nov 30, 2011·Journal of Diabetes Investigation·Hiroshi IkegamiYumiko Kawabata
Jul 31, 2010·Journal of Oncology·Claudia PapewalisMatthias Schott
Feb 21, 2009·Molecular Endocrinology·Gautam RajpalPeter Arvan
Jan 1, 2012·The Review of Diabetic Studies : RDS·Kate L GrahamThomas W H Kay
Jan 1, 2012·The Review of Diabetic Studies : RDS·Cathleen PetzoldKarsten Kretschmer
Feb 8, 2014·Diabetes Management·Dan XuStephen D Miller
Feb 7, 2014·Annual Review of Immunology·Emil R Unanue
Oct 27, 2012·Advanced Drug Delivery Reviews·Kwang-Chul KwonHenry Daniell
Oct 29, 2010·Expert Review of Clinical Immunology·Rodolfo José Chaparro, Teresa P Dilorenzo
Nov 8, 2008·Expert Opinion on Biological Therapy·Maria KatsaraVasso Apostolopoulos
Sep 2, 2015·Proceedings of the National Academy of Sciences of the United States of America·Anthony N VomundEmil R Unanue
Apr 3, 2010·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Takashi AraiMasao Nagata
Apr 22, 2010·Drug Discovery Today. Disease Models·T L Van BelleM G von Herrath
Mar 10, 2009·Trends in Endocrinology and Metabolism : TEM·Margret WuttkeMatthias Schott
Sep 17, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Wen-Chia HuangHsin-Cheng Chiu
Mar 19, 2009·Clinical and Experimental Immunology·S I ManneringL C Harrison
Nov 3, 2010·Immunology·Jeffrey BabadTeresa P DiLorenzo
Oct 18, 2012·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·J W MeeusenV A Lennon
Nov 10, 2011·Diabetes/metabolism Research and Reviews·Li ZhangGeorge S Eisenbarth
Apr 4, 2015·Carbohydrate Polymers·Li-Chan YangWen-Chuan Lin
Mar 30, 2016·Journal of Autoimmunity·Stephen T FerrisEmil R Unanue
May 29, 2009·Journal of Autoimmunity·Johanna LempainenJorma Ilonen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.